cyclosporine has been researched along with Huntington Disease in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 8 (88.89) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gellerich, FN; Gizatullina, Z; Landwehrmeyer, B; Nguyen, HP; Riess, O; Seppet, E; Striggow, F; Trumbeckaite, S; Vielhaber, S; von Hörsten, S; Zierz, S | 1 |
| Choo, YS; Detloff, PJ; Johnson, GV; Lesort, M; MacDonald, M | 1 |
| Greenamyre, JT; Lund, S; Panov, AV | 1 |
| Cattaneo, E; Goffredo, D; Rigamonti, D; Tartari, M; Valenza, M; Zuccato, C | 1 |
| Hernández-Espinosa, D; Morton, AJ | 1 |
| Baimbridge, KG; Church, J; Fernandes, HB; Hayden, MR; Raymond, LA | 1 |
| Barker, RA; Brooks, DJ; Chaudhuri, KR; Clough, C; Mason, S; Pavese, N; Piccini, P; Polkey, CE; Reuter, I; Tai, YF | 1 |
| Kondoh, T; Low, WC; Pundt, LL | 1 |
| Bachoud-Lévi, A; Barba, GD; Bartolomeo, P; Boissé, MF; Bourdet, C; Brugières, P; Cesaro, P; Defer, GL; Degos, JD; Ergis, AM; Grandmougin, T; Haddad, B; Hantraye, P; Jény, R; Lefaucheur, JP; Lisovoski, F; Nguyen, JP; Pailhous, E; Palfi, S; Peschanski, M; Rémy, P | 1 |
2 trial(s) available for cyclosporine and Huntington Disease
| Article | Year |
|---|---|
Long-term clinical and positron emission tomography outcome of fetal striatal transplantation in Huntington's disease.
Topics: Adrenergic Uptake Inhibitors; Adult; Brain Edema; Brain Tissue Transplantation; Carbon Radioisotopes; Case-Control Studies; Caudate Nucleus; Combined Modality Therapy; Corpus Striatum; Cyclosporine; Dopamine Antagonists; Female; Fetal Tissue Transplantation; Follow-Up Studies; Humans; Huntington Disease; Immunosuppressive Agents; Lymphocytosis; Male; Middle Aged; Morpholines; Neurologic Examination; Neuropsychological Tests; Positron-Emission Tomography; Postoperative Complications; Putamen; Raclopride; Reboxetine; Stereotaxic Techniques; Tissue Survival | 2008 |
Safety and tolerability assessment of intrastriatal neural allografts in five patients with Huntington's disease.
Topics: Adult; Brain Tissue Transplantation; Cognition; Corpus Striatum; Cyclosporine; Family; Female; Fetal Tissue Transplantation; Follow-Up Studies; Humans; Huntington Disease; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Middle Aged; Patient Satisfaction; Postoperative Care; Preoperative Care; Safety; Treatment Outcome | 2000 |
7 other study(ies) available for cyclosporine and Huntington Disease
| Article | Year |
|---|---|
Impaired regulation of brain mitochondria by extramitochondrial Ca2+ in transgenic Huntington disease rats.
Topics: Animals; Brain; Calcium; Cell Death; Coloring Agents; Cyclosporine; Energy Metabolism; Enzyme Inhibitors; Humans; Huntingtin Protein; Huntington Disease; Membrane Potential, Mitochondrial; Mitochondria; Nerve Tissue Proteins; Nuclear Proteins; Oxygen Consumption; Rats; Rats, Transgenic; Ruthenium Red | 2008 |
Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release.
Topics: Adenosine Triphosphate; Animals; Calcium; Cell Line; Cyclosporine; Cytochromes c; Humans; Huntingtin Protein; Huntington Disease; Intracellular Membranes; Ion Channels; Mice; Mitochondria, Liver; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Mutation; Nerve Tissue Proteins; Nuclear Proteins; Recombinant Proteins; Serotonin Plasma Membrane Transport Proteins | 2004 |
Ca2+-induced permeability transition in human lymphoblastoid cell mitochondria from normal and Huntington's disease individuals.
Topics: Adenosine Diphosphate; Adolescent; Animals; Calcium; Cations, Divalent; Cyclosporine; Enzyme Inhibitors; Humans; Huntingtin Protein; Huntington Disease; Leukocytes; Mitochondria; Mitochondrial Swelling; Nerve Tissue Proteins; Nuclear Proteins; Oligomycins; Permeability; Rats | 2005 |
Prevention of cytosolic IAPs degradation: a potential pharmacological target in Huntington's Disease.
Topics: Animals; Apoptosis Regulatory Proteins; Brain; Carrier Proteins; Cell Line; Cell Survival; Cyclosporine; Cytosol; High-Temperature Requirement A Serine Peptidase 2; Humans; Huntingtin Protein; Huntington Disease; Inhibitor of Apoptosis Proteins; Intracellular Signaling Peptides and Proteins; Mice; Mitochondria; Mitochondrial Proteins; Mutation; Nerve Tissue Proteins; Nuclear Proteins; Proteins; Pyrimidinones; Serine Endopeptidases; Thiones; Ubiquitin-Protein Ligases; X-Linked Inhibitor of Apoptosis Protein | 2005 |
Calcineurin inhibitors cause an acceleration of the neurological phenotype in a mouse transgenic for the human Huntington's disease mutation.
Topics: Analysis of Variance; Animals; Blood Glucose; Calcineurin; Calcineurin Inhibitors; Cyclosporine; Disease Models, Animal; Glycosuria; Humans; Huntington Disease; Immunohistochemistry; Immunosuppressive Agents; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Mutation; Psychomotor Performance; Tacrolimus; Time Factors; Trinucleotide Repeat Expansion | 2006 |
Mitochondrial sensitivity and altered calcium handling underlie enhanced NMDA-induced apoptosis in YAC128 model of Huntington's disease.
Topics: Animals; Apoptosis; Bongkrekic Acid; Calcium; Calcium Signaling; Cells, Cultured; Cyclosporine; Disease Models, Animal; Excitatory Amino Acid Agonists; Fluorescent Dyes; Huntington Disease; Ionophores; Mice; Mice, Neurologic Mutants; Mitochondria; N-Methylaspartate; Neurotoxins; Patch-Clamp Techniques; Receptors, N-Methyl-D-Aspartate; Trinucleotide Repeat Expansion | 2007 |
NADPH-diaphorase histochemistry and functional analysis of human fetal striatal brain tissue transplanted into a rodent model of Huntington's disease.
Topics: Animals; Biomarkers; Brain Tissue Transplantation; Cyclosporine; Disease Models, Animal; Fetal Tissue Transplantation; Histocytochemistry; Humans; Huntington Disease; Motor Activity; NADPH Dehydrogenase; Neuropeptide Y; Rats; Rats, Sprague-Dawley; Rotation; Somatostatin | 1994 |